The Roche CMV IgG Elecsys reagent kit (REF 4784596190) is an electrochemiluminescence immunoassay (ECLIA) intended for the in vitro determination of immunoglobulin G antibodies directed against cytomegalovirus (CMV) in human serum and plasma. The assay is designed for use on Roche cobas e immunoassay analyzers and supports laboratory workflows requiring CMV serostatus assessment as part of broader infectious disease screening panels.

Key Features
- Methodology: Electrochemiluminescence immunoassay (ECLIA) based on the Elecsys sandwich/bridging principle using recombinant CMV antigens.
- Platform compatibility: Roche cobas e immunoassay analyzers (specific module compatibility per manufacturer IFU).
- Sample types: Human serum and plasma as defined in the manufacturer instructions for use.
- Result reporting: Qualitative and semi-quantitative IgG results expressed in U/mL against the Elecsys CMV IgG calibration.
- Ready-to-use cassette format with onboard reagent handling to streamline laboratory operations.
- Tests per kit: Not specified in the located sources.

Clinical Applications
- Determination of CMV IgG serostatus as part of infectious disease laboratory testing.
- Support of pre-transplant donor and recipient screening workflows where CMV serology is required.
- Serological assessment in prenatal and antenatal testing panels per local laboratory protocols.
- Use within TORCH-related serology panels alongside other Elecsys infectious disease assays.
- Specific intended use, indications and limitations: refer to the official Roche Elecsys CMV IgG Instructions for Use.

Product Information
- Brand: Roche
- Product: CMV IgG Elecsys
- REF / UPN: 4784596190
- Category: Roche Reagents
- Assay technology: Elecsys ECLIA
- Storage and stability: Not specified in the located sources; refer to the official Roche IFU and packaging.
- Regulatory status: Not specified in the located sources; verify regional registration prior to procurement.